Search filters

List of works by Lorenzo Fornaro

A dose finding and pharmacokinetic study of capecitabine in combination with oxaliplatin and irinotecan in metastatic colorectal cancer.

scientific article published on 7 October 2008

Anti-HER agents in gastric cancer: from bench to bedside ⬇️

scientific article published on 07 June 2011

Association of NOS3 and ANGPT2 gene polymorphisms with survival in patients with hepatocellular carcinoma receiving sorafenib: results of the multicenter prospective INNOVATE study

scientific article published on 05 May 2020

Bevacizumab in the pre-operative treatment of locally advanced rectal cancer: a systematic review.

scientific article published on May 2014

Bevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trial

scientific article published on 9 August 2010

Bone metastases in biliary cancers: A multicenter retrospective survey

scientific article published on 07 April 2018

Capecitabine after gastrectomy for advanced gastric cancer: have we got the patient right?

scientific article published on 4 November 2009

Cetuximab plus irinotecan after irinotecan failure in elderly metastatic colorectal cancer patients: clinical outcome according to KRAS and BRAF mutational status.

scientific article published on 8 July 2010

Comment on: 'Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort'.

scientific article published on 28 April 2016

Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trial.

scientific article published on 18 January 2015

Correlation between LDH levels and response to sorafenib in HCC patients: an analysis of the ITA.LI.CA database

scientific article published on January 2015

Dissecting signaling pathways in hepatocellular carcinoma: new perspectives in medical therapy

scientific article published on February 2014

EGFR and K-Ras mutations in women with lung adenocarcinoma: implications for treatment strategy definition

scientific article

EZH2 polymorphism and benefit from bevacizumab in colorectal cancer: another piece to the puzzle

scientific article published on 01 March 2012

Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancer.

scientific article

FOLFOXIRI in combination with panitumumab as first-line treatment in quadruple wild-type (KRAS, NRAS, HRAS, BRAF) metastatic colorectal cancer patients: a phase II trial by the Gruppo Oncologico Nord Ovest (GONO).

scientific article published on 10 May 2013

Factors predicting survival in patients with locally advanced pancreatic cancer undergoing pancreatectomy with arterial resection

scientific article published on 25 September 2020

Faithful markers of circulating cancer stem cells: is CD133 sufficient for validation in clinics?

scientific article published on 25 July 2011

First-line treatment with FOLFOXIRI for advanced pancreatic cancer in clinical practice: Patients' outcome and analysis of prognostic factors.

scientific article published on 2 April 2016

Genome-epigenome interactions: the Polycomb paradox

scientific article published on 01 February 2014

Immune Checkpoint Inhibitors in Esophageal Cancers: are we Finally Finding the Right Path in the Mist?

scientific article published on 28 February 2020

In reply

scientific article published on 24 September 2020

Liver metastases from colorectal cancer: how to best complement medical treatment with surgical approaches.

scientific article

Long-term outcome of initially unresectable metastatic colorectal cancer patients treated with 5-fluorouracil/leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) followed by radical surgery of metastases

scientific article published in March 2009

Molecular and pathological characterization of the EZH2 rs3757441 single nucleotide polymorphism in colorectal cancer

scientific article published on 9 November 2015

Multivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancer.

scientific article

Optimal approach to potentially resectable liver metastases from colorectal cancer

scientific article published on 01 October 2008

Outcome of second-line treatment after first-line chemotherapy with the GONO FOLFOXIRI regimen.

scientific article

Pharmacoepigenetics in gastrointestinal tumors: MGMT methylation and beyond

scientific article published on January 2016

Pharmacokinetics, a main actor in a many-sided approach to severe 5-FU toxicity prediction

scientific article published on 5 November 2008

Phase II study of sequential cisplatin plus 5-fluorouracil/leucovorin (5-FU/LV) followed by irinotecan plus 5-FU/LV followed by docetaxel plus 5-FU/LV in patients with metastatic gastric or gastro-oesophageal junction adenocarcinoma.

scientific article published on 17 March 2010

Prognosis of mucinous histology for patients with radically resected stage II and III colon cancer.

scientific article

Prognostic relevance of a T-type calcium channels gene signature in solid tumours: A correlation ready for clinical validation

scientific article published on 28 August 2017

Prognostic value of CD133 caused by mutant K-Ras and B-Raf--letter

scientific article published on 18 July 2012

Randomized trial of two induction chemotherapy regimens in metastatic colorectal cancer: an updated analysis.

scientific article

Refractory neuroendocrine tumor-response to liposomal doxorubicin and capecitabine.

scientific article published in November 2009

Second-line chemotherapy in advanced biliary cancer progressed to first-line platinum-gemcitabine combination: a multicenter survey and pooled analysis with published data

scientific article

Second-line chemotherapy in advanced biliary cancer: the present now will later be past

scientific article published on 13 August 2014

Second-line therapy for advanced pancreatic cancer: evaluation of prognostic factors and review of current literature

scientific article published on 17 February 2016

Second-line treatment efficacy and toxicity in older vs. non-older patients with advanced gastric cancer: A multicentre real-world study

scientific article published on 11 December 2018

TP53 Mutation Analysis in Gastric Cancer and Clinical Outcomes of Patients with Metastatic Disease Treated with Ramucirumab/Paclitaxel or Standard Chemotherapy

scientific article published on 24 July 2020

The emerging role of liquid biopsy in diagnosis, prognosis and treatment monitoring of pancreatic cancer

scientific article published on 06 December 2018

Topoisomerase 1 Promoter Variants and Benefit from Irinotecan in Metastatic Colorectal Cancer Patients.

scientific article published on 31 August 2016

Total neoadjuvant approach with FOLFOXIRI plus bevacizumab followed by chemoradiotherapy plus bevacizumab in locally advanced rectal cancer: the TRUST trial

scientific article published on 07 February 2019

Trans-Arterial Radioembolization for Hepatocellular Carcinoma

scientific article published on 23 September 2015

Paulina is supported by:

About Paulina

Help